Evidence map›Paper›PMID 30321295›Full record

ArticleBioinformatics (Oxford, England)2019

SCALOP: sequence-based antibody canonical loop structure annotation.

Wing Ki Wong, Guy Georges, Francesca Ros, Sebastian Kelm, Alan P Lewis, Bruck Taddese, Jinwoo Leem, Charlotte M Deane

Open access · hybridAbstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Building Representation Learning Models for Antibody Comprehension.Cold Spring Harbor perspectives in biology · 2024
    Review
  10. Article
  11. Article
  12. Learned features of antibody-antigen binding affinity.Frontiers in molecular biosciences · 2023
    Article
  13. Specific attributes of the VFrontiers in immunology · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. A Review of Deep Learning Methods for Antibodies.Antibodies (Basel, Switzerland) · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Wing Ki WongDepartment of Statistics, University of Oxford, Oxford, UK.
Guy GeorgesRoche Pharma Research and Early Development, Large Molecule Research Roche Innovation Center Munich, Penzberg, Germany.
Francesca RosRoche Pharma Research and Early Development, Large Molecule Research Roche Innovation Center Munich, Penzberg, Germany.
Sebastian KelmUCB Pharma, Slough, UK.
Alan P LewisComputational and Modelling Sciences, GlaxoSmithKline Research and Development, Stevenage, UK.
Bruck TaddeseAntibody Discovery and Protein Engineering, MedImmune, Granta Park, Cambridge, UK.
Jinwoo LeemDepartment of Statistics, University of Oxford, Oxford, UK.
Charlotte M DeaneDepartment of Statistics, University of Oxford, Oxford, UK.
University of Oxford · GBRoche Pharma AG (Germany) · DEGlaxoSmithKline (United Kingdom) · GBUCB Pharma (United Kingdom) · GB

Funding

Medical Research Council
6 · The paper itself

Abstract

motivationCanonical forms of the antibody complementarity-determining regions (CDRs) were first described in 1987 and have been redefined on multiple occasions since. The canonical forms are often used to approximate the antibody binding site shape as they can be predicted from sequence. A rapid predictor would facilitate the annotation of CDR structures in the large amounts of repertoire data now becoming available from next generation sequencing experiments.

resultsSCALOP annotates CDR canonical forms for antibody sequences, supported by an auto-updating database to capture the latest cluster information. Its accuracy is comparable to that of a standard structural predictor but it is 800 times faster. The auto-updating nature of SCALOP ensures that it always attains the best possible coverage. AVAILABILITY AND IMPLEMENTATION: SCALOP is available as a web application and for download under a GPLv3 license at opig.stats.ox.ac.uk/webapps/scalop. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.

Indexed as

SoftwareAntibodiesBinding Sites, AntibodyComplementarity Determining RegionsModels, MolecularAntibodiesComplementarity Determining Regions

Identifiers

PMID30321295
PMCPMC6513161
OpenAlexW2897159829

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.